| Timings |
Topic |
Speaker |
| 0830 - 0930 |
Registration and refreshments |
|
| 0930 |
JBDS-IP: a year in review and looking ahead |
Dr Omar Mustafa, Chair, JBDS-IP
Consultant diabetologist, King’s College Hospital NHS Foundation Trust, London |
| |
Session 1 Chair: Dr Omar Mustafa |
| |
Inpatient diabetes: GIRFT |
Professor Gerry Rayman, Consultant Diabetologist, East Suffolk and North Essex NHS Foundation Trust, Ipswich and GIRFT Diabetes Co-Lead NHSE
|
| |
Inpatient diabetes care: safety, accreditation, quality, new national audit |
Dr Daniel Flanagan, Consultant in diabetes and endocrinology,
University Hospitals Plymouth NHS Trust, Plymouth
Clinical Lead, Diabetes Care Accreditation programme and National Diabetes Audit (Inpatient Care)
|
| |
Update on new JBDS-IP guidelines |
| |
The use of variable rate intravenous insulin infusion (VRIII) in medical inpatients |
Dr Stella George, Consultant in diabetes and endocrinology, East and North Hertfordshire NHS Trust, Stevenage
|
| |
Using technology to support diabetes care in hospital |
Dr Pari Avari, Consultant Diabetologist, Imperial College Healthcare NHS Trust, London
|
| |
Refreshments |
| |
Session 2: A year in inpatient diabetes
Chair Professor Ketan Dhatariya, Chair ABCD
Updates on key clinical, research, and innovations developments in inpatient diabetes from speakers from the UK and internationally.
|
| |
Practical approaches for inpatient continuous glucose monitoring, insulin pumps, and automated insulin delivery systems: International position statement |
Dr Mikkel T. Olsen, Steno Diabetes Center Copenhagen, Herlev, Denmark
|
| |
PREM in inpatient diabetes |
Dr Olga Kozlowska, Oxford Institute of Applied Health Research, Oxford Brookes University, Oxford
Dr Rustam Rea, Consultant diabetologist, Oxford University Hospitals NHS Foundation Trust, Oxford
|
| |
Health Services Safety Investigations Body (HSSIB) report: Insulin: supporting safe administration in inpatient settings |
Mr Craig Hadley, Senior Safety Investigator, Health Services Safety Investigations Body (HSSIB) |
| |
Optimising inpatient management of steroid induced hyperglycaemia: Insulin dosing strategies and diabetes technology |
Dr Angela Chen, Consultant endocrinologist, Department of Endocrinology, Flinders Medical Centre, Bedford Park, Australia. |
| |
Feasibility of using algorithm-guided basal–bolus therapy in corticosteroid-treated inpatients using routine clinical data |
Ms Petra Martina Baumann, Medical University of Graz |
| |
Session 3: Workshops
• All attendees rotate through all 3 workshops.
• In the workshops, we aim to encourage a case based approach with interaction from the audience to achieve a set of learning outcomes. Focus on a ‘how to approach’
|
| |
Lunch, posters and exhibition |
| |
Workshop 1: Optimising inpatient diabetes care and safe discharge
Facilitators:
Esther Walden, Diabetes specialist nurse, Norfolk and Norwich University Hospital and Senior Clinical Adviser at Diabetes UK
Dr Stella George, Consultant Diabetes and Endocrinology, East and North Hertfordshire Teaching NHS Trust, Stevenage
|
| |
Workshop 2: use of diabetes technology in hospital
Facilitators:
Alison Cox, Diabetes specialist nurse, University College London Hospitals, London
Dr Pari Avari
Consultant Diabetologist, Imperial College Healthcare NHS Trust, London
|
| |
Refreshments |
| |
Workshop 3: Perioperative care of people with diabetes undergoing surgery
Facilitators:
Kim Howson, Diabetes Perioperative Specialist Nurse, James Paget University Hospitals NHS Foundation Trust, Great Yarmouth
Dr Nicholas Levy, Consultant anaesthetist, West Suffolk NHS Foundation Trust Bury St Edmunds, Suffolk
|
| |
Closing plenary:
Unanswered questions in inpatient diabetes: Future directions for care and research
• Key evidence gaps and unresolved challenges in inpatient diabetes management
• Emerging and future research priorities
• Translating innovation into sustainable improvements in hospital care
• Opportunities for international collaboration and learning
|
Professor Guillermo E. Umpierrez, Professor of Medicine
Emory University School of Medicine, Atlanta, Georgia, USA
|
| 1620 |
Closing remarks and awards |
